Preliminary study on the effectiveness of low doses of Rituximab in patients with Graves orbitopathy (GO) poorly responding to immunosuppressive steroid treatment.

Trial Profile

Preliminary study on the effectiveness of low doses of Rituximab in patients with Graves orbitopathy (GO) poorly responding to immunosuppressive steroid treatment.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Jul 2014

At a glance

  • Drugs Rituximab (Primary)
  • Indications Graves ophthalmopathy
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 01 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top